FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Theodore White

Research Profile

Living Beings

Chemicals & Drugs

Procedures

Physiology

Disorders

Candidiasis

Phenomena

Genes & Molecular Sequences

Genes, MDR

Co-author Network

Publications

TOP 3
Rebecca Rashid Achterman; Theodore C White
Dermatophyte virulence factors: identifying and analyzing genes that may contribute to chronic or acute skin infections.
Rebecca R Achterman; Adam R Smith; Brian G Oliver; Theodore C White
Sequenced dermatophyte strains: growth rate, conidiation, drug susceptibilities, and virulence in an invertebrate model.
Samantha J Hoot; Adam R Smith; Ryan P Brown; Theodore C White
An A643V amino acid substitution in Upc2p contributes to azole resistance in well-characterized clinical isolates of Candida albicans.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Theodore White (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Rebecca Rashid Achterman; Theodore C White
Dermatophyte virulence factors: identifying and analyzing genes that may contribute to chronic or acute skin infections.
International journal of microbiology 2012;2012():358305.
2011: Rebecca R Achterman; Adam R Smith; Brian G Oliver; Theodore C White
Sequenced dermatophyte strains: growth rate, conidiation, drug susceptibilities, and virulence in an invertebrate model.
Fungal genetics and biology : FG & B 2011;48(3):335-41.
2011: Samantha J Hoot; Adam R Smith; Ryan P Brown; Theodore C White
An A643V amino acid substitution in Upc2p contributes to azole resistance in well-characterized clinical isolates of Candida albicans.
Antimicrobial agents and chemotherapy 2011;55(2):940-2.
2010: Samantha J Hoot; Ryan P Brown; Brian G Oliver; Theodore C White
The UPC2 promoter in Candida albicans contains two cis-acting elements that bind directly to Upc2p, resulting in transcriptional autoregulation.
Eukaryotic cell 2010;9(9):1354-62.
2010: Bryce E Mansfield; Hanna N Oltean; Brian G Oliver; Samantha J Hoot; Sarah E Leyde; Lizbeth Hedstrom; Theodore C White
Azole drugs are imported by facilitated diffusion in Candida albicans and other pathogenic fungi.
PLoS pathogens 2010;6(9):e1001126.
2008: Samantha J Hoot; Brian G Oliver; Theodore C White
Candida albicans UPC2 is transcriptionally induced in response to antifungal drugs and anaerobicity through Upc2p-dependent and -independent mechanisms.
Microbiology (Reading, England) 2008;154(Pt 9):2748-56.
2008: Theresa S Richards; Brian G Oliver; Theodore C White
Micafungin activity against Candida albicans with diverse azole resistance phenotypes.
The Journal of antimicrobial chemotherapy 2008;62(2):349-55.
2008: Brian G Oliver; Peter M Silver; Theodore C White
Polyene susceptibility is dependent on nitrogen source in the opportunistic pathogen Candida albicans.
The Journal of antimicrobial chemotherapy 2008;61(6):1302-8.
2008: Peter M Silver; Brian G Oliver; Theodore C White
Characterization of caspofungin susceptibilities by broth and agar in Candida albicans clinical isolates with characterized mechanisms of azole resistance.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2008;46(3):231-9.
2008: Brian G Oliver; Peter M Silver; Chelsea Marie; Samantha J Hoot; Sarah E Leyde; Theodore C White
Tetracycline alters drug susceptibility in Candida albicans and other pathogenic fungi.
Microbiology (Reading, England) 2008;154(Pt 3):960-70.
2007: Brian G Oliver; Jia L Song; Jake H Choiniere; Theodore C White
cis-Acting elements within the Candida albicans ERG11 promoter mediate the azole response through transcription factor Upc2p.
Eukaryotic cell 2007;6(12):2231-9.
2006: Tige R Rustad; Jake H Choiniere; Dexter H Howard; Theodore C White
The Candida albicans mating type like locus [MTL] is not involved in chlamydospore formation.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2006;44(7):677-81.
2005: Theodore C White; Peter M Silver
Regulation of sterol metabolism in Candida albicans by the UPC2 gene.
Biochemical Society transactions 2005;33(Pt 5):1215-8.
2005: Jo Beth Harry; Brian G Oliver; Jia L Song; Peter M Silver; John T Little; Jake H Choiniere; Theodore C White
Drug-induced regulation of the MDR1 promoter in Candida albicans.
Antimicrobial agents and chemotherapy 2005;49(7):2785-92.
2004: Peter M Silver; Brian G Oliver; Theodore C White
Role of Candida albicans transcription factor Upc2p in drug resistance and sterol metabolism.
Eukaryotic cell 2004;3(6):1391-7.
2004: Jia L Song; Jo Beth Harry; Richard Eastman; Brian G Oliver; Theodore C White
The Candida albicans lanosterol 14-alpha-demethylase (ERG11) gene promoter is maximally induced after prolonged growth with antifungal drugs.
Antimicrobial agents and chemotherapy 2004;48(4):1136-44.
2003: Jia L Song; Chris N Lyons; Scott Holleman; Brian G Oliver; Theodore C White
Antifungal activity of fluconazole in combination with lovastatin and their effects on gene expression in the ergosterol and prenylation pathways in Candida albicans.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2003;41(5):417-25.
2003: Jia L Song; Theodore C White
RAM2: an essential gene in the prenylation pathway of Candida albicans.
Microbiology (Reading, England) 2003;149(Pt 1):249-59.
2002: Jacqueline R Starr; Theodore C White; Brian G Leroux; Henrique Luis; Mario Bernardo; Jorge Leitao; Marilyn C Roberts
Persistence of oral Candida albicans carriage in healthy Portuguese schoolchildren followed for 3 years.
Oral microbiology and immunology 2002;17(5):304-10.
2002: Theodore C White; Scott Holleman; Francis Dy; Laurence F Mirels; David A Stevens
Resistance mechanisms in clinical isolates of Candida albicans.
Antimicrobial agents and chemotherapy 2002;46(6):1704-13.
2002: Tige R Rustad; David A Stevens; Michael A Pfaller; Theodore C White
Homozygosity at the Candida albicans MTL locus associated with azole resistance.
Microbiology (Reading, England) 2002;148(Pt 4):1061-72.
2002: Jo Beth Harry; Jia L Song; Chris N Lyons; Theodore C White
Transcription initiation of genes associated with azole resistance in Candida albicans.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2002;40(1):73-81.
2001: Kieren Marr; Chris N Lyons; K Ha; Tige R Rustad; Theodore C White
Inducible azole resistance associated with a heterogeneous phenotype in Candida albicans.
Antimicrobial agents and chemotherapy 2001;45(1):52-9.
2000: Chris N Lyons; Theodore C White
Transcriptional analyses of antifungal drug resistance in Candida albicans.
Antimicrobial agents and chemotherapy 2000;44(9):2296-303.
2000: Kieren Marr; K Seidel; Theodore C White; Raleigh A Bowden
Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole.
The Journal of infectious diseases 2000;181(1):309-16.
1999: Kieren Marr; Tige R Rustad; J H Rex; Theodore C White
The trailing end point phenotype in antifungal susceptibility testing is pH dependent.
Antimicrobial agents and chemotherapy 1999;43(6):1383-6.
1999: K C Ha; Theodore C White
Effects of azole antifungal drugs on the transition from yeast cells to hyphae in susceptible and resistant isolates of the pathogenic yeast Candida albicans.
Antimicrobial agents and chemotherapy 1999;43(4):763-8.
1998: Jo-Anne H van Burik; R W Schreckhise; Theodore C White; Raleigh A Bowden; David Myerson
Comparison of six extraction techniques for isolation of DNA from filamentous fungi.
Medical mycology : official publication of the International Society for Human and Animal Mycology 1998;36(5):299-303.
1998: Kieren Marr; Chris N Lyons; Tige R Rustad; Raleigh A Bowden; Theodore C White; T Rustad
Rapid, transient fluconazole resistance in Candida albicans is associated with increased mRNA levels of CDR.
Antimicrobial agents and chemotherapy 1998;42(10):2584-9.
1998: Theodore C White; Kieren Marr; Raleigh A Bowden
Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.
Clinical microbiology reviews 1998;11(2):382-402.
1997: Kieren Marr; Theodore C White; Jo-Anne H van Burik; Raleigh A Bowden
Development of fluconazole resistance in Candida albicans causing disseminated infection in a patient undergoing marrow transplantation.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;25(4):908-10.
1997: Theodore C White
The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14alpha demethylase in Candida albicans.
Antimicrobial agents and chemotherapy 1997;41(7):1488-94.
1997: Theodore C White
Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus.
Antimicrobial agents and chemotherapy 1997;41(7):1482-7.